Total Payments
$13,519
2024 Payments
$1,506
Companies
52
Transactions
885
Medicare Patients
10,526
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$13,415 (99.2%)
Education$104.32 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,415 | 869 | 99.2% |
| Education | $104.32 | 16 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,180 | 185 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,882 | 106 | $0 (2024) |
| PFIZER INC. | $1,180 | 90 | $0 (2024) |
| Lilly USA, LLC | $1,051 | 76 | $0 (2024) |
| Amgen Inc. | $961.65 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $741.05 | 47 | $0 (2024) |
| GlaxoSmithKline, LLC. | $589.32 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $570.63 | 34 | $0 (2023) |
| ABBVIE INC. | $494.24 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $464.44 | 37 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,506 | 80 | AstraZeneca Pharmaceuticals LP ($448.36) |
| 2023 | $1,172 | 66 | AstraZeneca Pharmaceuticals LP ($239.67) |
| 2022 | $1,564 | 97 | Novo Nordisk Inc ($317.40) |
| 2021 | $1,943 | 126 | Novo Nordisk Inc ($254.29) |
| 2020 | $1,952 | 123 | AstraZeneca Pharmaceuticals LP ($337.74) |
| 2019 | $1,823 | 137 | Novo Nordisk Inc ($363.25) |
| 2018 | $1,722 | 130 | Novo Nordisk Inc ($298.03) |
| 2017 | $1,838 | 126 | Novo Nordisk Inc ($292.21) |
All Payment Transactions
885 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $68.33 | General |
| Category: Hematology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardio-renal | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardio-renal | ||||||
| 09/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,223 | 3,573 | $744,255 | $325,795 |
| 2022 | 12 | 2,506 | 3,733 | $733,440 | $323,386 |
| 2021 | 15 | 2,874 | 4,095 | $725,947 | $333,392 |
| 2020 | 19 | 2,923 | 4,099 | $740,703 | $293,253 |
Total Patients
10,526
Total Services
15,500
Medicare Billing
$1.3M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 794 | 2,035 | $447,700 | $176,628 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 657 | 657 | $157,680 | $83,547 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 502 | 611 | $91,650 | $35,877 | 39.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 59 | 59 | $23,600 | $16,652 | 70.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 34 | 34 | $11,560 | $5,580 | 48.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 28 | 28 | $2,800 | $2,123 | 75.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 56 | $1,960 | $1,715 | 87.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 55 | $1,925 | $1,685 | 87.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,080 | $1,418 | 34.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 26 | 26 | $1,300 | $569.40 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 810 | 1,744 | $383,680 | $152,497 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 687 | 687 | $164,880 | $90,501 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 632 | 921 | $138,150 | $55,077 | 39.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 42 | 42 | $14,280 | $7,102 | 49.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 22 | $10,450 | $4,968 | 47.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $4,700 | $3,037 | 64.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 159 | 159 | $3,975 | $2,992 | 75.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 38 | 38 | $3,800 | $2,670 | 70.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,120 | $1,997 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 54 | 54 | $1,890 | $1,616 | 85.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $665.00 | $571.53 | 85.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 17 | 17 | $850.00 | $358.53 | 42.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 759 | 1,626 | $357,720 | $153,783 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 662 | 662 | $158,880 | $88,972 | 56.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 655 | 992 | $148,800 | $62,102 | 41.7% |
About Dr. Mark Evangelista, M.D
Dr. Mark Evangelista, M.D is a Internal Medicine healthcare provider based in Seaford, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700036241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Evangelista, M.D has received a total of $13,519 in payments from pharmaceutical and medical device companies, with $1,506 received in 2024. These payments were reported across 885 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($13,415).
As a Medicare-enrolled provider, Evangelista has provided services to 10,526 Medicare beneficiaries, totaling 15,500 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Seaford, DE
- Active Since 09/21/2008
- Last Updated 03/07/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700036241
Products in Payments
- FARXIGA (Drug) $1,179
- Ozempic (Drug) $1,021
- TRULICITY (Drug) $599.64
- CHANTIX (Drug) $469.82
- ELIQUIS (Drug) $417.24
- JARDIANCE (Drug) $409.10
- TRELEGY ELLIPTA (Drug) $401.80
- Rybelsus (Drug) $365.81
- XARELTO (Drug) $362.57
- ENTRESTO (Drug) $338.66
- VRAYLAR (Drug) $298.76
- BREZTRI (Drug) $290.06
- Kerendia (Drug) $260.92
- Tresiba (Drug) $256.41
- STIOLTO RESPIMAT (Drug) $229.16
- Aimovig (Biological) $225.75
- TEGSEDI (Drug) $223.51
- EVENITY (Biological) $201.11
- TRADJENTA (Drug) $192.18
- Saxenda (Drug) $188.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Seaford
Dr. Jeffrey Elfenbein, D.o, D.O
Internal Medicine — Payments: $27,890
Internal Medicine $27,890
Dr. Richard Simons, D.o, D.O
Internal Medicine — Payments: $7,910
Internal Medicine $7,910
Dr. Angel Alicea, M.d, M.D
Internal Medicine — Payments: $7,728
Internal Medicine $7,728
Dr. Louis Crevecoeur, Md, MD
Internal Medicine — Payments: $5,826
Internal Medicine $5,826
Alvaro Buenano, M.d, M.D
Internal Medicine — Payments: $5,198
Internal Medicine $5,198
Dr. Ronald Luna, Md, MD
Internal Medicine — Payments: $3,522
Internal Medicine $3,522